BioCentury
ARTICLE | Finance

Listing single

How Chinese precision medicine play 3DMed is charting course to public markets

February 16, 2018 9:31 PM UTC

Chinese cancer company 3D Medicines Corp. is vying for a Hong Kong or NASDAQ listing this year and is restructuring as a Cayman Islands-based entity in order to tap public funds while keeping its diagnostics and therapeutics businesses under one roof.

3DMed markets next-generation sequencing-based cancer diagnostics in China and is developing a pipeline of cancer therapies for the global market. ...